"Uncovering the Untapped Potential of Anti-Aging Drugs and Longevity Clinics"

Dr. Nir Barzilai, a leading longevity researcher, has identified four promising but overlooked anti-aging drugs: Metformin, Rapamycin, ACE inhibitors, and SGLT2 inhibitors. These drugs have shown potential in extending lifespan and improving age-related health issues, such as reducing inflammation, cancer risk, and improving immune function. Despite being already available and relatively low-cost, these drugs struggle to attract investment due to their generic nature. However, they offer potential for treating aging-related conditions and are backed by established safety and efficacy data.